GILD Gilead Sciences Earnings and EPS analysis

EPS in 2025 (TTM): $4.77

Last Report Period Date: Mar 31, 2025

According to the most recent financial data from March 2025, the EPS for the trailing twelve months is $4.77. Gilead Sciences's EPS for 2024 amounted to $0.38, marking a drop from $4.54 in 2023. During the quarterly period ending on Mar 31, 2025, GILD's EPS stood at $1.06.

Gilead Sciences had an annual EPS of $0.38, indicating a drop of 91.6% from $4.54 in 2023. The quarterly per-share earnings for the period ending Mar 31, 2025, was $1.06, indicating a 131.7% increase from the same quarter last year. GILD's 12-month EPS stands at $4.77 as of March 2025. Gilead Sciences's annual EPS in 2023 stood at $4.54, a 24% increase year-over-year.

During the last 12 months, Gilead Sciences has seen an EPS growth of 131.7% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of -57.5% per year. During the last 5 years, the company had an average EPS growth rate of -38.3%. When measured over a ten-year period, GILD's average EPS growth rate was -26.2%.